Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes.

@article{Sjoberg2011ModerateWL,
  title={Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes.},
  author={Nicholas J Sjoberg and Grant D Brinkworth and Thomas Philip Wycherley and Manny Noakes and David A. Saint},
  journal={Journal of applied physiology},
  year={2011},
  volume={110 4},
  pages={1060-4}
}
The objective of this study was to determine the effects of weight loss on heart rate variability (HRV) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes. Forty five patients [body mass index (BMI) 35.4 ± 0.7 kg/m²; age 56.5 ± 1.1 yr] with type 2 diabetes followed an energy-restricted diet (6-7 MJ/day) for 16 wk. Body weight, blood pressure, glucose, insulin, insulin resistance [homeostasis model assessment index 2… CONTINUE READING

2 Figures & Tables

Connections & Topics

Mentioned Connections BETA
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Mean reduction in body weight was 11.1 ± 1.0 kg ( 10% ) , with significant reductions in blood pressure ( -10% ) , total cholesterol ( -15.9% ) , LDL ( -17.7% ) , HDL ( -7.5% ) , triglycerides ( -21.2% ) , glucose ( -23.4% ) , insulin ( -37.6% ) , HOMA2 ( -40.1% ) , and HbA1c ( -14.5% ) ( P ≤ 0.05 for all variables ) .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Mean reduction in body weight was 11.1 ± 1.0 kg ( 10% ) , with significant reductions in blood pressure ( -10% ) , total cholesterol ( -15.9% ) , LDL ( -17.7% ) , HDL ( -7.5% ) , triglycerides ( -21.2% ) , glucose ( -23.4% ) , insulin ( -37.6% ) , HOMA2 ( -40.1% ) , and HbA1c ( -14.5% ) ( P ≤ 0.05 for all variables ) .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Mean reduction in body weight was 11.1 ± 1.0 kg ( 10% ) , with significant reductions in blood pressure ( -10% ) , total cholesterol ( -15.9% ) , LDL ( -17.7% ) , HDL ( -7.5% ) , triglycerides ( -21.2% ) , glucose ( -23.4% ) , insulin ( -37.6% ) , HOMA2 ( -40.1% ) , and HbA1c ( -14.5% ) ( P ≤ 0.05 for all variables ) .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Body weight , blood pressure , glucose , insulin , insulin resistance [ homeostasis model assessment index 2 ( HOMA2 ) ] , glycosylated hemoglobin ( HbA1c ) , total cholesterol , low - density lipoproteins ( LDL ) , high - density lipoproteins ( HDL ) , triglycerides , resting HR , and HRV were measured before and after the intervention period .
Mean reduction in body weight was 11.1 ± 1.0 kg ( 10% ) , with significant reductions in blood pressure ( -10% ) , total cholesterol ( -15.9% ) , LDL ( -17.7% ) , HDL ( -7.5% ) , triglycerides ( -21.2% ) , glucose ( -23.4% ) , insulin ( -37.6% ) , HOMA2 ( -40.1% ) , and HbA1c ( -14.5% ) ( P ≤ 0.05 for all variables ) .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
Moderate weight loss improves heart rate variability in overweight and obese adults with type 2 diabetes .
The objective of this study was to determine the effects of weight loss on heart rate variability ( HRV ) and its association with traditional cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes .
In addition to improvements in traditional cardiovascular and metabolic risk factors , weight loss improves HRV in overweight and obese patients with type 2 diabetes .
All Topics